Company intelligence / Profile preview

Aleap

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Aleap is the largest health startup incubator in the Nordics, providing tailored support for early-stage life science and healthcare ventures. It offers regulatory guidance, business development expertise, infrastructure, and access to networks. Through its venture arm (Aleap Ventures), it invests in MedTech, BioTech, and Digital Health startups across the Nordic region. It also co-runs Norway’s first national biotechnology accelerator ("The Forge") with Digital Life Norway.

Modalities: Small moleculeBiologicDeviceDigital health solutions
Industry: Investors

Partnerships

Digital Life Norway ("The Forge" accelerator partner)Research Council of Norway funding via DLN pilot activitiesCo-investment with angels/family offices/VCsAcademic collaborations via accelerator programs

Beyond the preview

Go deeper on Aleap.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aleap.

Explore the full profile